Characteristics of Redox-Metabolism in Patients with Metastatic Colorectal Cancer: Clinical Significance

Cancer Science & Research ◽

10.33425/2639-8478.1058 ◽

2020 ◽

Vol 3 (4) ◽

Author(s):

Burlaka AP ◽

Gafurov MR ◽

Burlaka AA ◽

Ganusevich II

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Clinical Significance ◽

Redox Metabolism

Download Full-text

Review: Incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2011.06.004 ◽

2011 ◽

Vol 37 (9) ◽

pp. 737-746 ◽

Author(s):

D. Hompes ◽

T. Ruers

Keyword(s):

Colorectal Cancer ◽

Adverse Events ◽

Metastatic Colorectal Cancer ◽

Clinical Significance ◽

Serious Adverse Events

Download Full-text

Analysis of tumor morphology in metastatic colorectal cancer: does this classification have any clinical significance?

Journal of Gastroenterology ◽

10.1007/s005350200132 ◽

2002 ◽

Vol 37 (10) ◽

pp. 791-797 ◽

Author(s):

Atsushi Nanashima ◽

Hiroyuki Yamaguchi ◽

Terumitsu Sawai ◽

Shinichi Shibasaki ◽

Toru Yasutake ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Clinical Significance ◽

Tumor Morphology

Download Full-text

Clinical significance of peripheral circulating tumor cell counts in colorectal polyps and non-metastatic colorectal cancer

World Journal of Surgical Oncology ◽

10.1186/s12957-017-1305-2 ◽

2018 ◽

Vol 16 (1) ◽

Author(s):

Chengguang Yang ◽

Wenfang Zhuang ◽

Yuemei Hu ◽

Leiming Zhu

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Clinical Significance ◽

Circulating Tumor Cell ◽

Colorectal Polyps ◽

Download Full-text

Clinical Significance of Discordance between Carcinoembryonic Antigen Levels and RECIST in Metastatic Colorectal Cancer

Cancer Research and Treatment ◽

10.4143/crt.2016.537 ◽

2018 ◽

Vol 50 (1) ◽

pp. 283-292 ◽

Author(s):

In-Ho Kim ◽

Ji Eun Lee ◽

Ji Hyun Yang ◽

Joon Won Jeong ◽

Sangmi Ro ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Carcinoembryonic Antigen ◽

Clinical Significance

Download Full-text

Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.12784 ◽

2017 ◽

Vol 14 (3) ◽

pp. 239-246 ◽

Author(s):

In-Ho Kim ◽

Ji Eun Lee ◽

Ji Hyun Yang ◽

Joon Won Jeong ◽

Sangmi Ro ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Carcinoembryonic Antigen ◽

Clinical Significance ◽

Inflammatory Markers ◽

Cancer Prognosis ◽

Chemotherapy Response

Download Full-text

P-255 The clinical significance of the gut microbiota in RAS wild-type metastatic colorectal cancer patients treated with anti-EGFR monoclonal antibodies in combination with chemotherapy – preliminary results

Annals of Oncology ◽

10.1016/j.annonc.2021.05.309 ◽

2021 ◽

Vol 32 ◽

pp. S185

Author(s):

T. Lewandowski ◽

P. Stelmasiak ◽

J. Stefańska ◽

R. Wolinowska ◽

B. Bobrowska ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Gut Microbiota ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Clinical Significance ◽

Wild Type ◽

Preliminary Results ◽

Colorectal Cancer Patients

Download Full-text

Clinical significance of thymidine kinase 1 expression on TAS-102 treatment in RECOURSE phase III trial of TAS-102 versus placebo for metastatic colorectal cancer

Annals of Oncology ◽

10.1093/annonc/mdw370.112 ◽

2016 ◽

Vol 27 ◽

pp. vi186

Author(s):

K. Yamazaki ◽

T. Yoshino ◽

E. Shinozaki ◽

Y. Komatsu ◽

Y. Tsuji ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Thymidine Kinase ◽

Clinical Significance ◽

Phase Iii ◽

Thymidine Kinase 1 ◽

Phase Iii Trial

Download Full-text

Reply to `Comment on `Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study''

British Journal of Cancer ◽

10.1038/s41416-018-0040-y ◽

2018 ◽

Vol 118 (9) ◽

pp. 1278-1279

Author(s):

Eiji Shinozaki ◽

Takayuki Yoshino ◽

Katsuya Tsuchihara

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Monoclonal Antibodies ◽

Metastatic Colorectal Cancer ◽

Clinical Significance ◽

Cancer Genomics ◽

Therapeutic Effects ◽

Antibody Treatment ◽

Monoclonal Antibody Treatment ◽

Biomarker Research

Download Full-text

Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer

The Pharmacogenomics Journal ◽

10.1038/s41397-021-00207-x ◽

2021 ◽

Author(s):

Mitsukuni Suenaga ◽

Marta Schirripa ◽

Shu Cao ◽

Wu Zhang ◽

Chiara Cremolini ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Clinical Significance ◽

Gene Polymorphisms ◽

Download Full-text

Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study

British Journal of Cancer ◽

10.1038/bjc.2017.308 ◽

2017 ◽

Vol 117 (10) ◽

pp. 1450-1458 ◽

Author(s):

Eiji Shinozaki ◽

Takayuki Yoshino ◽

Kentaro Yamazaki ◽

Kei Muro ◽

Kensei Yamaguchi ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Monoclonal Antibodies ◽

Metastatic Colorectal Cancer ◽

Clinical Significance ◽

Cancer Genomics ◽

Therapeutic Effects ◽

Antibody Treatment ◽

Monoclonal Antibody Treatment ◽

Biomarker Research

Download Full-text